Primary study · included by 1 review
Systematic evaluation of salivary gland damage following I-131 therapy in differentiated thyroid cancer patients by quantitative scintigraphy and clinical follow-up
Wu 2015 · Wu Ju-qing, Feng Hui-juan, Ouyang Wei, et al. · Nuclear Medicine Communications · 2015
Included by
| Outcome this study informs | Pooled effect | Evidence | Certainty |
|---|---|---|---|
Xerostomia (pooled prevalence) Radioiodine (I131) therapy · within 2 months after RIT | Prevalence 0.60 [0.28, 0.85] | 3 studies · 1502 participants | GRADE not reported |
Xerostomia High administered I131 activity (study-specific thresholds) vs Low administered I131 activity (study-specific thresholds) | OR 7.14 [2.02, 25.26] | 3 studies | GRADE not reported |
Xerostomia High administered I131 activity (study-specific thresholds) vs Low administered I131 activity (study-specific thresholds) | OR 4.23 [1.04, 17.15] | 4 studies | GRADE not reported |
1 including review in total.